The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment. © 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted.
Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review / Palomba, Stefano; Materazzo, Caterina; Falbo, Angela; Orio, Francesco; LA SALA, Giovanni Battista; Sultan, Charles. - In: GYNECOLOGICAL ENDOCRINOLOGY. - ISSN 0951-3590. - 30:5(2014), pp. 335-340. [10.3109/09513590.2013.876001]
Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review
Palomba, Stefano;LA SALA, Giovanni Battista;
2014
Abstract
The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment. © 2014 Informa UK Ltd. All rights reserved: reproduction in whole or part not permitted.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Palomba S 2014 Gynecol Endocrinol.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
296.41 kB
Formato
Adobe PDF
|
296.41 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
